Daily Stock Picks The 10 year bond is key - it's clear we are in a downward market now - 10-20-23 Market Update
The 10 year bond rate hitting 5% is what's killing stocks. It's clear we are now seeing the market continue lower from here. Be careful what stocks you look to trade and look for opportunities to add to a long term buy.
Get my algo and a special offer on Trendspider - https://trendspider.com?_go=gary93
Get $50 off a year of Seeking Alpha. https://www.sahg6dtr.com/2L9M597/R74QP/
TESLA referral -Use my referral link to buy a Tesla and get up to $500 off and 3 months of Full Self-Driving Capability.
https://www.tesla.com/referral/gary82526
Social Links and more - https://linktr.ee/dailystockpick
FREE NEWSLETTER WITH CHARTS - subscribe at dailystockpick.substack.com
SPONSORED BY VISIBLE - Check out this page: https://www.visible.com/get/?3P8FJPM $20 off your first month - only $5 for the first month
Sign up for Webull and get free stocks like I did -
https://a.webull.com/IStte9iTQnfaDYFoCt
Get AT&T Fiber at your home - I have 1GB service https://www.att.com/referral/code/?ref=TVY-3964
NOTES
https://finviz.com/published_map.ashx?t=sec&st=d1&f=102023&i=sec_d1_083094199
The 10 year bond hit 5% and Powell thinks bond auctions have been fine even with no buyers showing up
$gehc
$UNH Insider sale at $540 - $65M from a director who exercised those options and immediately sold. The exercise was for $9M so he made a cool $55M
Understanding the mathematical principles of profitable trading can help a trader understand how to create a positive expectancy trading system with an edge. The understanding of the underlying math can change how you look at your own trading and see what really matters: risk per trade, win rate, losing streaks, drawdowns, positive expectancy, and growth rate.
The math that a trader needs to understand is not complex and can be summarized into a few of the most important core dynamics. Below is the math a trader needs on one cheat sheet. Use these formulas to unlock your own profitable strategy.
Shares plunged 20% after the solar company lowered its third-quarter revenue guidance to between $720 million and $730 million, down from prior guidance of between $880 million and $920 million. CEO Zvi Lando said the company experienced “substantial unexpected” cancellations and pushouts of existing backlog from its European distributors. Enphase Energy and First Solar lost 14% and 4.9%, respectively, on the back of SolarEdge’s downbeat news.
"substantial unexpected cancellations and pushouts of existing backlog from our European distributors," due to higher than expected inventory in the channels and slower than expected installation rates
https://x.com/stockmarketnerd/status/1715103649565692191?s=46&t=7y4v-tHaIEzjLo4Lw72X7g
$MARA is up because of this - Bitcoin up over $30k
$LLY eying shots for kids for their weight loss drugs
ETFs: (NYSEARCA:USO BNO UCO SCO USL DBO DRIP GUSH NRGU USQI
Shares of Jazz Pharmaceuticals added more than 5% in pre-market trading, after Bloomberg reported that the Ireland-based drugmaker was exploring strategic options, including a potential sale of the company. Jazz is most well-known for being the developer of the blockbuster narcolepsy drug Xyrem. As per the report, JAZZ was also looking into the possibility of separating its cannabinoid and oncology businesses.
SCANS
$TSM
Levered ETF’s - all on the short side
$SRTY
$SMDD
$SDOW
$DRV
$FAZ
$SDS
$HIBS
$SPXU